BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 19706425)

  • 1. Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system.
    Stegbauer J; Lee DH; Seubert S; Ellrichmann G; Manzel A; Kvakan H; Muller DN; Gaupp S; Rump LC; Gold R; Linker RA
    Proc Natl Acad Sci U S A; 2009 Sep; 106(35):14942-7. PubMed ID: 19706425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative effects of different modes of renin angiotensin system inhibition on hypercholesterolaemia-induced atherosclerosis.
    Lu H; Balakrishnan A; Howatt DA; Wu C; Charnigo R; Liau G; Cassis LA; Daugherty A
    Br J Pharmacol; 2012 Mar; 165(6):2000-2008. PubMed ID: 22014125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of the Protective Arm of the Renin Angiotensin System in Demyelinating Disease.
    Stone RE; Liu S; Levy AM; Kashani N; Louie SG; Rodgers KE; Kelland EE; Lund BT
    J Neuroimmune Pharmacol; 2020 Jun; 15(2):249-263. PubMed ID: 31828731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. AT1 antagonism and renin inhibition in mice: pivotal role of targeting angiotensin II in chronic kidney disease.
    Fraune C; Lange S; Krebs C; Hölzel A; Baucke J; Divac N; Schwedhelm E; Streichert T; Velden J; Garrelds IM; Danser AH; Frenay AR; van Goor H; Jankowski V; Stahl R; Nguyen G; Wenzel UO
    Am J Physiol Renal Physiol; 2012 Oct; 303(7):F1037-48. PubMed ID: 22791343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is aliskiren superior to inhibitors of angiotensin-converting enzyme and angiotensin receptor blockers in renin-angiotensin system blockade?
    Gerc V; Buksa M; Loza V; Kulic M
    Med Arh; 2009; 63(6):343-9. PubMed ID: 20380117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent changes in the landscape of combination RAS blockade.
    Epstein BJ; Smith SM; Choksi R
    Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [How I treat... by optimizing the blockade of the renin-angiotensin-aldosterone system].
    Schleich F; Krzesinski JM; Piérard L; Scheen AJ
    Rev Med Liege; 2008 Apr; 63(4):174-81. PubMed ID: 18575070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac Inflammation after Ischemia-Reperfusion of the Kidney: Role of the Sympathetic Nervous System and the Renin-Angiotensin System.
    Panico K; Abrahão MV; Trentin-Sonoda M; Muzi-Filho H; Vieyra A; Carneiro-Ramos MS
    Cell Physiol Biochem; 2019; 53(4):587-605. PubMed ID: 31535830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antigen-oriented T cell migration contributes to myelin peptide induced-EAE and immune tolerance.
    Zheng P; Fu H; Wei G; Wei Z; Zhang J; Ma X; Rui D; Meng X; Ming L
    Clin Immunol; 2016 Aug; 169():36-46. PubMed ID: 27327113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renin-angiotensin system dual blockade using angiotensin receptor plus aliskiren decreases severe proteinuria in kidney transplant recipients.
    López V; Martin M; Cobelo C; Aranda P; Cabello M; Sola E; Gutierrez C; Burgos D; Martínez D; Hernandez D
    Transplant Proc; 2010 Oct; 42(8):2883-5. PubMed ID: 20970559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct renin inhibition in addition to or as an alternative to angiotensin converting enzyme inhibition in patients with chronic systolic heart failure: rationale and design of the Aliskiren Trial to Minimize OutcomeS in Patients with HEart failuRE (ATMOSPHERE) study.
    Krum H; Massie B; Abraham WT; Dickstein K; Kober L; McMurray JJ; Desai A; Gimpelewicz C; Kandra A; Reimund B; Rattunde H; Armbrecht J;
    Eur J Heart Fail; 2011 Jan; 13(1):107-14. PubMed ID: 21169387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The future of renin inhibition].
    Uresin AY; Baran E
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination renin-angiotensin system blockade with the renin inhibitor aliskiren in hypertension.
    Doulton TW; MacGregor GA
    J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):185-9. PubMed ID: 19617273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The comparative efficacy of renin-angiotensin system blockers in schistosomal hepatic fibrosis.
    Parreira NA; Ramalho FS; Augusto MJ; Silva DM; Prado CM; Elias Júnior J; Rodrigues V; Ramalho LNZ
    Exp Parasitol; 2018 Aug; 191():9-18. PubMed ID: 29890165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renin-angiotensin system blockade is renoprotective in immune complex-mediated glomerulonephritis.
    Guo S; Kowalewska J; Wietecha TA; Iyoda M; Wang L; Yi K; Spencer M; Banas M; Alexandrescu S; Hudkins KL; Alpers CE
    J Am Soc Nephrol; 2008 Jun; 19(6):1168-76. PubMed ID: 18337487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-angiotensin system blocking drugs.
    Robles NR; Cerezo I; Hernandez-Gallego R
    J Cardiovasc Pharmacol Ther; 2014 Jan; 19(1):14-33. PubMed ID: 24038019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Involvement of regulatory T cells in the experimental autoimmune encephalomyelitis-preventive effect of dendritic cells expressing myelin oligodendrocyte glycoprotein plus TRAIL.
    Hirata S; Matsuyoshi H; Fukuma D; Kurisaki A; Uemura Y; Nishimura Y; Senju S
    J Immunol; 2007 Jan; 178(2):918-25. PubMed ID: 17202353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of a triple blockade of the renin-angiotensin-system in recurrent focal segmental glomerulosclerosis after kidney transplantation.
    Freiberger V; Amann K; Heemann U; Frank H
    Transpl Int; 2009 Nov; 22(11):1110-3. PubMed ID: 19497068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Renin inhibition and the kidney].
    Ecder T
    Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():28-31. PubMed ID: 20019474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma.
    Coulson R; Liew SH; Connelly AA; Yee NS; Deb S; Kumar B; Vargas AC; O'Toole SA; Parslow AC; Poh A; Putoczki T; Morrow RJ; Alorro M; Lazarus KA; Yeap EFW; Walton KL; Harrison CA; Hannan NJ; George AJ; Clyne CD; Ernst M; Allen AM; Chand AL
    Oncotarget; 2017 Mar; 8(12):18640-18656. PubMed ID: 28416734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.